 |
 |
 |
 |
 |
 |
|
November 21, 2011 November 8, 2011 |
19-21 March 2012
Bio-Europe Spring 2012
Amsterdam RAI Convention Centre, The Netherlands
31 March-4 April 2012
AACR Annual Meeting 2012
Chicago, USA
18-21 June 2012
2012 BIO International Convention
Boston, USA
Aglaia identifies groundbreaking opportunities in cancer research and, in close partnerships with inventors and entrepreneurs, takes these opportunities to the next phase of technical and commercial development.
In its commitment to create and build biomedical companies in the field of oncology, Aglaia does not only provide the financial means but also takes an active role in strategic and operational processes.
Aglaia Biomedical Ventures B.V. currently has two investment funds under management: Aglaia Oncology Fund B.V.and Aglaia Oncology Seed Fund B.V.
